Search Results
Found 1 results
510(k) Data Aggregation
(259 days)
XPANDORTHO, INC.
The XO1 Knee Balancing System is intended for use as a tool for adjustment of soft tissue to reduce instability from flexion gap asymmetry in total knee replacement procedures.. The XO1 Knee Balancing System requires a resected tibial bone and may only be used with an intact femur, trial femoral implant. The force sensor is sterile, for single patient use.
Not Found
This FDA letter, K162237, for the XO1 Knee Balancing System, does not contain the detailed acceptance criteria or the study data proving the device meets those criteria. The provided text is a 510(k) clearance letter from the FDA, which confirms that the device is substantially equivalent to a predicate device already on the market. It outlines the indications for use but does not delve into the specific performance studies, acceptance criteria, or the methodology of such studies.
Therefore, I cannot extract the requested information regarding acceptance criteria, study details, sample sizes, ground truth establishment, expert qualifications, or MRMC studies from the provided document. The document primarily focuses on regulatory clearance rather than detailed performance study reports.
Ask a specific question about this device
Page 1 of 1